With 30 states enrolling children in child welfare through managed care delivery systems, it is imperative that states and health plans use administrative and clinical practices designed to address the very complex lives of this group of children. With changing placements -- and caregivers -- the ability to coordinate and manage care provided by different practitioners is challenging at best. For children who rely on psychotropic medications to address their behavioral health conditions, the need to effectively manage and monitor these medications is critical.
During this webinar, participants heard from Dr. Peter Jensen about evidence-based and promising practices related to the use of psychotropic medication among children involved in child welfare and the critical role of families as partners in care.
Peter S. Jensen, MD, President, The REACH Institute
Psychotropic Medication Use in Children Involved in Child Welfare: The State of the Science and Practice